9 November 2021 (Tuesday) - Fritsma Factor Update

 

The Fritsma Factor newsletter appeared in my in-box this morning. You can read it by clicking here. As always I’m grateful for any CPD, and especially grateful for anything haemostasis-related.

8 November 2021 (Monday) - DIgital Morphology NEQAS


I had a look at the digital morphology NEQAS a month ago. We were told that "an elderly man with no previous history of haematological disease has been admitted to hospital. He is anaemic with a raised white cell count. " Which is far more forthcoming that most NEQAS morphology excercises are, but was still frankly rather sparse compared with real0llife cases.
I had a look and saw:

Wbc (in order of priority)

Vacuolated neuts
Dohle body
Myelocytes (with peri-nuclear halo)
Left-shifted neuts
Monocytes

Rbc (in order of priority)

Basophilic stippling
Nucleated rbc
stomatocytes
Polychromasia
Target cells
Anisocytosis

Plt

reduced

I felt that this was possibly a case of sepsis (or Jordan's anomaly) in someone with a haemolytic condition. And I said that “without more information any further speculation is frankly guesswork”.

The final report said “It is certainly possible that the polychromasia and nucleated cells reflect a bone marrow response to red cell destruction. However, the abnormal erythrocyte forms present are not typical of red cell fragmentation, membrane disorder, or abnormal haemoglobin. We should therefore consider that bone marrow infiltration (particularly a myelodysplastic syndrome) may be present causing the expulsion of immature and maturing”…

“This is a patient with chronic myelomonocytic leukaemia who had experienced a deterioration in his health following an infection. The features have been described in the narrative, but the diagnosis is not simple. Without full knowledge of the number of monocytes, and a review after the infection is resolved, it is not possible to be fully confident that this is chronic myelomonocytic leukaemia. However, the extensive dysplastic features present should allow a diagnosis of probably underlying myelodysplasia; and a possible diagnosis of CMML could be suggested”.

I spotted the salient features which could equally well be applied to what I thought it was as well as what it supposedly was.

8 November 2021 (Monday) - Oncologist Update

The nice people at “The Oncologist” sent their update today. rather clinical, and quite a bit of very little relevance to me, but there were a couple of snippets in there… there usually is.

Selections From This Issue:

Commentaries

 

Advertisement

Racism and Cancer Care

 

Adherence to Endocrine Therapy and Racial Outcome Disparities in Breast Cancer

Katherine E. Reeder‐Hayes, Melissa A. Troester, Stephanie B. Wheeler

Precision Medicine Clinic: Molecular Tumor Board

 

BRCA Germline and Sporadic Pancreatic Cancer

Steven Sorscher, Shakti Ramkissoon

RTK Mosaicism in Glioblastoma

Daniel J. Shepherd, Tyler E. Miller, Deborah A. Forst et al.

Clinical Trial Results

 

Phase I Trial of SGN‐2FF in Patients with Advanced Solid Tumors

Khanh T. Do, Laura Quan Man Chow, Karen Reckamp et al.

Articles

 

A Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer

Romualdo Barroso‐Sousa, Ines Vaz‐Luis, Antonio Di Meglio et al.

Patient Understanding of Molecular Testing Terminology

Shannon M. Blee, Rachel Pocock Shah, Ana P.M. Pinheiro et al.

Advertisement

Sunitinib and Evofosfamide Metastatic Pancreatic Neuroendocrine Tumors

Enrique Grande, Cristina Rodriguez‐Antona, Carlos López et al.

Temozolomide in Grade 3 GI Neuroendocrine Neoplasms

David L. Chan, Emily K. Bergsland, Jennifer A. Chan et al.

Outcomes and Racial Disparities in Hormone‐Sensitive Prostate Cancer

Katherine Emilie Rhoades Smith, Jacqueline Theresa Brown, Limeng Wan et al.

Outcomes and Health Care Utilization in Older Adults with Aggressive NHL

P. Connor Johnson, Alisha Yi, Nora Horick et al.

TKI‐Related Vascular AEs in Patients with CML

Mei‐Tsen Chen, Shih‐Tsung Huang, Chih‐Wan Lin et al.

EMA Review of Isatuximab for Multiple Myeloma

Julio Delgado, Malgorzata Zienowicz, Paula Boudewina van Hennik et al.

See the Full Issue